Boston's startups and tech companies were busy in September, pulling in collective billions from VCs and other investors. Here's who raised and what they pulled in:
Expansion Therapeutics, a Boston biotech company developing drugs for RNA-mediated diseases, raised $80M in Series B funding, led by Cormorant Asset Management.
Kytopen, a Cambridge-based developer of engineered cell therapy tech, raised $30M in Series A funding, led by Northpond Ventures.
Delix Therapeutics, a Boston-based neuroscience company developing psychedelic-inspired compounds to help treat mental health disorders, raised $70M in Series A financing, led by ARTIS Ventures, RA Capital Management, and OMX Ventures.
DNA data company Catalog raised $35M in a Series B round led by Hanwha Impact Partners, a sustainability-focused investment wing of the South Korean conglomerate Hanwha Group.
Akkio, a Cambridge company founded out of frustration with inefficient use of data and the inaccessibility of machine learning, announced that it raised $3M in seed funding.
Micronotes Inc., an AI-driven marketing automation company based in Boston, raised $1.3M in equity from 18 investors, according to an SEC filing.
Truconnect LLC, a Boston-based telecom startup, raised $8M in equity from six investors, according to an SEC filing.
RemNote, a Cambridge-based digital workspace for notetaking, raised $3M in seed funding led by General Catalyst.
Bluebird Bio, a Cambridge-based biotech company developing gene therapies, raised $74M in equity.
6k, a North Andover company producing materials for energy storage and additive manufacturing powders, announced that it closed a $51M Series C financing round. The fundraising was led by Volta Energy Technologies.
Cytrellis, a Woburn-based medical technology company, announced $50M in Series C investment, led by D1 Capital Partners.
SmartLabs, a Boston-based laboratory-as-a-service (LaaS) company, announced it raised a $250M Series B financing.
Santi Therapeutics Inc. of Waltham raised $10M.
Kendall Square-based travel company SmarterTravel rebranded as Hopjump and closed a $9.5M Series B funding round.
Boston-based Kappa Pay Inc. raised $2M as part of an offering worth $2.25M in options and other securities.
Kolide, a Boston-based endpoint security platform, announced that it raised $17M in a Series B investment, bringing the total funding to date to $27M.
Caresyntax, a Boston-based enterprise-level digital surgery platform, announced a $30M extension to its Series C funding round, initially led by PFM Health Sciences LP
FreightFlows, a Boston-based software company with a data platform for market analysis, disclosed $610K in debt financing from 17 investors in an SEC filing.
Boston-based Snyk Ltd., which builds security tools for developers, raised $530M in late-stage financing.
Boston-based cancer biotech Ankyra Therapeutics Inc. raised $45M in equity from 14 investors.
Watertown-based pharmaceutical company Windgap Medical Inc. raised more than $17M in equity.
HilleVax, a Boston biopharmaceutical company developing novel vaccine candidates, announced the closing of a $135M crossover financing led by Frazier Healthcare Partners.
Organ-on-a-chip maker Emulate closed a $82M Series E financing round led by existing investor Northpond Ventures with additional participation from Perceptive Advisors.
Centaur Labs, a Boston-based AI health care startup, disclosed $15M in Series A funding led by Matrix Partners.
Insurify Inc., a virtual insurance agent and platform for comparing insurance options, raised $100M in Series B funding from the New York private equity firm Motive Partners and MassMutual Ventures
Postaga, a Boston-based outreach platform that helps marketers improve their metrics, raised $180K in seed funding from the TinySeed accelerator program.
